You are here

BIOSURFACES INC

Company Information
Address
200 HOMER AVE UNIT 1P
ASHLAND, MA 01721-1717
United States


https://biosurfaces.us

Information

UEI: KML8NX2RNDD4

# of Employees: 11


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Development of Infection-Resistant Suture Materials

    Amount: $744,617.00

    DESCRIPTION (provided by applicant): Infection remains as one of the major complications associated with utilizing biomaterials. Surgical site infections account for approximately 14-16% of the 2.4-mi ...

    STTRPhase II2006Department of Health and Human Services National Institutes of Health
  2. Development of Infection-Resistant Suture Materials

    Amount: $744,617.00

    DESCRIPTION (provided by applicant): Infection remains as one of the major complications associated with utilizing biomaterials. Surgical site infections account for approximately 14-16% of the 2.4-mi ...

    SBIRPhase II2006Department of Health and Human Services National Institutes of Health
  3. A Nanofibrous Biocomposite Small-Diameter Graft

    Amount: $750,000.00

    DESCRIPTION (provided by applicant): There is no small-diameter (< 5mm internal diameter) vascular prosthesis approved for clinical use in small vessel reconstruction. Current prostheses are not ca ...

    SBIRPhase II2005Department of Health and Human Services National Institutes of Health
  4. Development of Infection-Resistant Suture Materials

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): Infection remains as one of the major complications associated with utilizing biomaterials. Surgical site infections account for approximately 14-16% of the 2.4 ...

    STTRPhase I2004Department of Health and Human Services National Institutes of Health
  5. Development of Infection-Resistant Suture Materials

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): Infection remains as one of the major complications associated with utilizing biomaterials. Surgical site infections account for approximately 14-16% of the 2.4 ...

    SBIRPhase I2004Department of Health and Human Services National Institutes of Health
  6. A Nanofibrous Biocomposite Small-Diameter Graft

    Amount: $200,000.00

    DESCRIPTION (provided by applicant): There is no small-diameter (< 5mm internal diameter) vascular prosthesis clinically available that is capable of emulating the biological and physical propertie ...

    SBIRPhase I2003Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government